Background Antiplatelet agents are recommended for people with myocardial infarction and
acute coronary syndromes, transient ischaemic attack or stroke, and for those in whom …

Background: Uncertainty remains about the effects of aspirin in patients with prior
percutaneous coronary intervention (PCI) having noncardiac surgery. Objective: To evaluate …

Platelet transfusions aim to improve primary hemostasis and to prevent or treat bleeding in
patients with reduced platelet numbers and/or platelet function. In this review, the authors …

Background. Myocardial injury after non-cardiac surgery (MINS), a complication with unclear
pathogenesis, occurs within the first 30 days after surgery and worsens prognosis …

BACKGROUND: Noncardiac surgery (NCS) following percutaneous coronary intervention
(PCI) with stenting is sometimes associated with major adverse cardiac events (MACEs) …

Elective non-cardiac surgery (NCS) should optimally be delayed one year after implantation
of a drug-eluting stent (DES). Dual antiplatelet therapy or at least aspirin is recommended to …

Tranexamic acid (TXA) is an antifibrinolytic which minimises bleeding and transfusions, with
thrombotic risk. Our patient had known coronary artery disease with post-TXA acute ST …

BACKGROUND: Patients with existing coronary artery stents are at an increased risk for
major adverse cardiac events (MACEs) when undergoing noncardiac surgery (NCS) …

Purpose We conducted a single-center retrospective study to evaluate the effects of
intraoperative hypotension (IOH) on postoperative myocardial injury during major …

Tranexamic acid (TXA) is an antifibrinolytic which minimises bleeding and transfusions, with
thrombotic risk. Our patient had known coronary artery disease with post-TXA acute ST …